Indirect protection from rotavirus vaccines: a systematic review
Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden. This systematic review summarizes estimates of indirect protection from rotavirus vaccines and the methods used to obtain these estimates. We identified 71 studies publishe...
Saved in:
Published in | Expert review of vaccines Vol. 23; no. 1; pp. 789 - 795 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis Group
2024
|
Subjects | |
Online Access | Get full text |
ISSN | 1476-0584 1744-8395 1744-8395 |
DOI | 10.1080/14760584.2024.2395534 |
Cover
Summary: | Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden.
This systematic review summarizes estimates of indirect protection from rotavirus vaccines and the methods used to obtain these estimates.
We identified 71 studies published between 2009 and 2022 that provided 399 estimates of indirect protection from rotavirus vaccine. Most estimates (73%) evaluated hospitalizations due to rotavirus gastroenteritis as the outcome and unvaccinated children <5 years old as the agegroup (64%), but there was considerable variability in methods to evaluate indirect protection. For hospitalizations due to rotavirus gastroenteritis among unvaccinated children <5 years old, the median incidence rate ratio was 0.60 (IQR: 0.40-0.87,
= 110 estimates), the median relative percent change in percent positivity was 25% (IQR: 13-44%,
= 49 estimates), and the median relative percent change in absolute number of rotavirus positive tests or rotavirus-specific International Classification of Diseases codes was 42% (IQR: 16-66%,
= 40 estimates).
These findings broadly suggest rotavirus vaccines provide some indirect protection. There is a need to standardize measurement of indirect rotavirus vaccine protection, particularly using consistent outcomes and metrics, and stratifying results by standardized age groups and years since vaccine introduction. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 ObjectType-Review-4 content type line 23 Author contribution statement: All authors should have substantially contributed to the conception and design of the review article and interpreting the relevant literature and were involved in writing the review article or revised it for intellectual content. |
ISSN: | 1476-0584 1744-8395 1744-8395 |
DOI: | 10.1080/14760584.2024.2395534 |